Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 946 AL 960

The Basis of Anti-Aβ Antibody Therapy: The Toxicity of Aβ Aggregates and the Mechanism of Action of Anti-Aβ Antibodies

Ono K, Noguchi-Shinohara M, Watanabe-Nakayama T.

Intern Med. 2026 Jan 1;65(1):41-45. doi: 10.2169/internalmedicine.4569-24. Epub 2024 Oct 4.

[Anti-Amyloid Antibody Therapy for Alzheimer's Disease]

Shinohara M, Ono K.

Brain Nerve. 2024 Oct;76(10):1119-1125. doi: 10.11477/mf.1416202747.

Sex- and dose-dependent catalase increase and its clinical impact in a benzoate dose-finding, randomized, double-blind, placebo-controlled trial for Alzheimer's disease

Lane HY, Wang SH, Lin CH.

Pharmacol Biochem Behav. 2024 Dec;245:173885. doi: 10.1016/j.pbb.2024.173885. Epub 2024 Oct 9.

Symposium: What Does the Microbiome Tell Us about Prevention and Treatment of AD/ADRD?

Capocchi JK, Figueroa-Romero C, Dunham SJB, Faraci G, Rothman JA, Whiteson KL, Seo DO, Holtzman DM, Grabrucker S, Nolan YM, Kaddurah-Daouk R, Jett DA.

J Neurosci. 2024 Oct 9;44(41):e1295242024. doi: 10.1523/JNEUROSCI.1295-24.2024.

Serotonin in depression and Alzheimer's disease: Focus on SSRI's beneficial effects

Tahiri J, Mian M, Aftan F, Habbal S, Salehi F, Reddy PH, Reddy AP.

Ageing Res Rev. 2024 Nov;101:102537. doi: 10.1016/j.arr.2024.102537. Epub 2024 Oct 9.

Exploring nanoparticular platform in delivery of repurposed drug for Alzheimer's disease: current approaches and future perspectives

Chakraborty S, Vishwas S, Harish V, Gupta G, Paudel KR, Dhanasekaran M, Goh BH, Zacconi F, de Jesus Andreoli Pinto T, Kumbhar P, Disouza J, Dua K, Singh SK.

Expert Opin Drug Deliv. 2024 Dec;21(12):1771-1792. doi: 10.1080/17425247.2024.2414768. Epub 2024 Oct 13.

Safety, tolerability, and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer's disease (ILiAD) study: a pilot, double-blind placebo-controlled crossover trial

Sen A, Toniolo S, Tai XY, Akinola M, Symmonds M, Mura S, Galloway J, Hallam A, Chan JYC, Koychev I, Butler C, Geddes J, Jones GD, Tabi Y, Maio R, Frangou E, Love S, Thompson S, Van Der Putt R, Manohar SG, McShane R, Husain M.

Epilepsia Open. 2024 Dec;9(6):2353-2364. doi: 10.1002/epi4.13070. Epub 2024 Oct 14.

Exploring the multiple therapeutic mechanisms and challenges of mesenchymal stem cell-derived exosomes in Alzheimer's disease

Ma YN, Hu X, Karako K, Song P, Tang W, Xia Y.

Biosci Trends. 2024 Nov 15;18(5):413-430. doi: 10.5582/bst.2024.01306. Epub 2024 Oct 11.

Anti-amyloid β Antibody Therapies for Alzheimer's Disease: Association between the Target of Amyloid β Aggregates and the Clinical Efficacy of Anti-amyloid β Antibody

Noguchi-Shinohara M, Ono K.

Intern Med. 2026 Jan 1;65(1):67-70. doi: 10.2169/internalmedicine.4604-24. Epub 2024 Oct 11.

Gut Microbiome in Alzheimer's Disease: from Mice to Humans

Liang C, Pereira R, Zhang Y, Rojas OL.

Curr Neuropharmacol. 2024;22(14):2314-2329. doi: 10.2174/1570159X22666240308090741.

Exploring the Benzazoles Derivatives as Pharmacophores for AChE, BACE1, and as Anti-Aβ Aggregation to Find Multitarget Compounds against Alzheimer's Disease

Rosales Hernández MC, Olvera-Valdez M, Velazquez Toledano J, Mendieta Wejebe JE, Fragoso Morales LG, Cruz A.

Molecules. 2024 Oct 9;29(19):4780. doi: 10.3390/molecules29194780.

Intrathecal Immunoselective Nanopheresis for Alzheimer's Disease: What and How? Why and When?

Menendez-Gonzalez M.

Int J Mol Sci. 2024 Oct 2;25(19):10632. doi: 10.3390/ijms251910632.

Brain Stimulation in Alzheimer's Disease Trials

Benussi A, Borroni B.

J Alzheimers Dis. 2024;101(s1):S545-S565. doi: 10.3233/JAD-230535.

Immunotherapy in Alzheimer's Disease: Current Status and Future Directions

Vashisth K, Sharma S, Ghosh S, Babu MA, Ghosh S, Iqbal D, Kamal M, Almutary AG, Jha SK, Ojha S, Bhaskar R, Jha NK, Sinha JK.

J Alzheimers Dis. 2024;101(s1):S23-S39. doi: 10.3233/JAD-230603.

Melatonin in Alzheimer's Disease: Literature Review and Therapeutic Trials

Steinbach MJ, Denburg NL.

J Alzheimers Dis. 2024;101(s1):S193-S204. doi: 10.3233/JAD-230760.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias